ALX ONCOLOGY HOLDINGS INC (ALXO) Stock Income Statement
NASDAQ:ALXO - Nasdaq - US00166B1052 - Common Stock - Currency: USD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 1.18M | 4.80M | |||
| Cost Of Goods | N/A | 0.00 | N/A | 1.08M | 4.36M | |||
| Gross Profit | N/A | 0.00 | N/A | 110.00K | 440.00K | |||
| Operating Expenses | 170.28M | 127.44M | 83.56M | 43.77M | 19.62M | |||
| Research and Development | 141.79M | 98.40M | 60.17M | 28.96M | 16.31M | |||
| Selling, General, and Administrative Expenses | 28.48M | 29.04M | 23.39M | 14.81M | 3.31M | |||
| Operating Income | -170.28M | -127.44M | -83.56M | -43.66M | -19.18M | |||
| Interest Income/Expense | 9.08M | 4.28M | -10.00K | -810.00K | -20.00K | |||
| Other Income/Expense | 389.00K | -260.00K | 80.00K | -400.00K | -10.00K | |||
| Non Recurring Items | N/A | 0.00 | 0.00 | -620.00K | N/A | |||
| Income Before Taxes | -160.81M | -123.42M | -83.48M | -45.50M | -19.21M | |||
| Income Tax | 0.00 | 60.00K | -20.00K | 240.00K | 30.00K | |||
| Net Income | -160.81M | -123.48M | -83.46M | -50.94M | -23.27M | |||
| EBITDA | -169.44M | -127.10M | -83.51M | -43.46M | -18.75M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.74 | -3.03 | -2.07 | -2.76 | -0.67 | |||
| Non GAAP EPS | -3.75 | -3.03 | -2.06 | -4.48 | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | 9.32% | 9.17% | |||
| Profit Margin | N/A | N/A | N/A | -4316.95% | -484.79% | |||
| Operating Profit Margin | N/A | N/A | N/A | -3700.00% | -399.58% | |||
All data in USD